![Coronavirus: Biontech-Impfstoff schützt laut Studiendaten auch Ältere zu mehr als 95 Prozent vor Infektionen - DER SPIEGEL Coronavirus: Biontech-Impfstoff schützt laut Studiendaten auch Ältere zu mehr als 95 Prozent vor Infektionen - DER SPIEGEL](https://cdn.prod.www.spiegel.de/images/bf2b4553-4863-4120-9763-09f81320dd76_w948_r1.778_fpx70.37_fpy44.98.jpg)
Coronavirus: Biontech-Impfstoff schützt laut Studiendaten auch Ältere zu mehr als 95 Prozent vor Infektionen - DER SPIEGEL
![BioNTech, Curevac and Co.: Patent Suspensions Threaten Germany's Booming Biotech Industry - DER SPIEGEL BioNTech, Curevac and Co.: Patent Suspensions Threaten Germany's Booming Biotech Industry - DER SPIEGEL](https://cdn.prod.www.spiegel.de/images/0e14d0a1-44bb-47f3-8357-4878e536b882_w948_r1.778_fpx51_fpy27.jpg)
BioNTech, Curevac and Co.: Patent Suspensions Threaten Germany's Booming Biotech Industry - DER SPIEGEL
![AstraZeneca and Pfizer/BioNTech: Germany Faces Dilemma of What to do with Excess Vaccine - DER SPIEGEL AstraZeneca and Pfizer/BioNTech: Germany Faces Dilemma of What to do with Excess Vaccine - DER SPIEGEL](https://cdn.prod.www.spiegel.de/images/1a2fb88d-bd78-4198-833f-d7eaba565d9e_w670_r0.7502857142857143_fpx50.96_fpy62.26.jpg)
AstraZeneca and Pfizer/BioNTech: Germany Faces Dilemma of What to do with Excess Vaccine - DER SPIEGEL
![Christian Tidona on Twitter: "Great to see how Germany's perception of us, the kids of immigrants, is changing over time. German Angst is eventually becoming the German Dream. #BioNTech #UgurSahin #ÖzlemTüreci #COVID19 # Christian Tidona on Twitter: "Great to see how Germany's perception of us, the kids of immigrants, is changing over time. German Angst is eventually becoming the German Dream. #BioNTech #UgurSahin #ÖzlemTüreci #COVID19 #](https://pbs.twimg.com/media/EqzDBgnXEAIb89-.jpg)
Christian Tidona on Twitter: "Great to see how Germany's perception of us, the kids of immigrants, is changing over time. German Angst is eventually becoming the German Dream. #BioNTech #UgurSahin #ÖzlemTüreci #COVID19 #
DER SPIEGEL - Wann kehren wir zum normalen Leben zurück? Im SPIEGEL-Interview macht Biontech-Chef Uğur Şahin Hoffnung – und spricht über die Fähigkeit seines Impfstoffs, Infektionen zu verhindern. (S+) | Facebook
![BioNTech Founders on Vaccine for Children: "Things Are Looking Good and Going According to Plan" - DER SPIEGEL BioNTech Founders on Vaccine for Children: "Things Are Looking Good and Going According to Plan" - DER SPIEGEL](https://cdn.prod.www.spiegel.de/images/78edccf9-ae8a-4f88-a57a-53374d96e4de_w948_r1.778_fpx53_fpy49.jpg)
BioNTech Founders on Vaccine for Children: "Things Are Looking Good and Going According to Plan" - DER SPIEGEL
![BioNTech Founders on Vaccine for Children: "Things Are Looking Good and Going According to Plan" - DER SPIEGEL BioNTech Founders on Vaccine for Children: "Things Are Looking Good and Going According to Plan" - DER SPIEGEL](https://cdn.prod.www.spiegel.de/images/e7df7215-757b-41a5-8495-4877594d7f27_w670_r0.7502857142857143_fpx50.96_fpy47.26.jpg)
BioNTech Founders on Vaccine for Children: "Things Are Looking Good and Going According to Plan" - DER SPIEGEL
![BioNTech Founder Şahin on the Omicron Variant: “It Will Make Scientific Sense To Offer Booster after Three Months” - DER SPIEGEL BioNTech Founder Şahin on the Omicron Variant: “It Will Make Scientific Sense To Offer Booster after Three Months” - DER SPIEGEL](https://cdn.prod.www.spiegel.de/images/87ce0c75-7634-45e7-9f58-f89a3625d5d8_w1600_r0.7725197177251972_fpx38_fpy39.jpg)
BioNTech Founder Şahin on the Omicron Variant: “It Will Make Scientific Sense To Offer Booster after Three Months” - DER SPIEGEL
DER SPIEGEL - Der von Biontech entwickelte Corona-Impfstoffkandidat war eine Sensation. Und: ein Hoffnungsschimmer. Im SPIEGEL-Interview sprechen Özlem Türeci und Uğur Şahin nun erstmals in einem großen gemeinsamen Gespräch über ihr Leben
![BioNTech CEO Uğur Şahin on mRNA-Technology: "We Have Opened the Door To a New World of Pharmaceuticals" - DER SPIEGEL BioNTech CEO Uğur Şahin on mRNA-Technology: "We Have Opened the Door To a New World of Pharmaceuticals" - DER SPIEGEL](https://cdn.prod.www.spiegel.de/images/ec03c2f5-0475-44ad-88ed-8bcd46920c3e_w1200_r1.33_fpx56_fpy35.jpg)